MARCIA BELVIN

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Christopher Ogden, as Attorney-in-Fact for Marcia Belvin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MARCIA BELVIN:

Company Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. SVP, Chief Scientific Officer Common Stock 332,252 $1,415,393 $4.26 02 Feb 2026 Direct
CytomX Therapeutics, Inc. SVP, Chief Scientific Officer Performance Stock Units (PSUs) 18,150 $0 $1.23 26 Sep 2025 Direct
CytomX Therapeutics, Inc. SVP, Chief Scientific Officer Stock Option (Right to Buy) 250,000 02 Feb 2026 Direct
CytomX Therapeutics, Inc. SVP, Chief Scientific Officer Performance Stock Units 0 13 Jun 2025 Direct

Insider Reports Filed by MARCIA BELVIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CTMX CytomX Therapeutics, Inc. 02 Feb 2026 2 $0 4 SVP, Chief Scientific Officer 04 Feb 2026, 16:25
CTMX CytomX Therapeutics, Inc. 26 Sep 2025 2 $0 4 SVP, Chief Scientific Officer 30 Sep 2025, 18:37
CTMX CytomX Therapeutics, Inc. 13 Jun 2025 3 -$37,334 4 SVP, Chief Scientific Officer 17 Jun 2025, 16:10
CTMX CytomX Therapeutics, Inc. 18 Mar 2025 1 -$11,688 4 SVP, Chief Scientific Officer 20 Mar 2025, 16:31
CTMX CytomX Therapeutics, Inc. 04 Feb 2025 4 $0 4/A SVP, Chief Scientific Officer 10 Feb 2025, 17:58
CTMX CytomX Therapeutics, Inc. 20 Aug 2024 3 -$5,139 4 SVP, Chief Scientific Officer 22 Aug 2024, 18:01
CTMX CytomX Therapeutics, Inc. 19 Mar 2024 1 -$26,684 4 SVP, Chief Scientific Officer 21 Mar 2024, 16:37
CTMX CytomX Therapeutics, Inc. 18 Jan 2024 3 $0 4 SVP, Chief Scientific Officer 19 Jan 2024, 20:38
CTMX CytomX Therapeutics, Inc. 20 Dec 2023 1 -$5,628 4 SVP, Chief Scientific Officer 22 Dec 2023, 16:14
CTMX CytomX Therapeutics, Inc. 17 Dec 2023 2 $0 4 SVP, Chief Scientific Officer 19 Dec 2023, 19:54
CTMX CytomX Therapeutics, Inc. 20 Sep 2023 2 -$5,356 4 SVP, Chief Scientific Officer 22 Sep 2023, 19:16
CTMX CytomX Therapeutics, Inc. 22 Mar 2023 1 $0 4 SVP, Chief Scientific Officer 29 Mar 2023, 19:54
CTMX CytomX Therapeutics, Inc. 22 Mar 2023 0 $0 3 SVP, Chief Scientific Officer 29 Mar 2023, 19:50